This study investigates COVID-19 by analyzing blood samples from individuals who have been clinically diagnosed as COVID-19 positive. COVID-19, also known as coronavirus disease 2019, is an infectious disease caused by the SARS-CoV-2 virus. Researchers aim to understand the immune response in those who have been infected.
Participants will be asked questions about their health, medications, and COVID-19 status. Blood samples will be collected four times over the study period. These samples will be tested for antibodies and other markers of immunity. Participants will be informed about their antibody test results.
- Who can participate: Individuals who have been clinically tested positive for COVID-19 can join the study.
- Study details: Participants will answer questions about their health and provide blood samples. Each blood draw will be compensated with $25. The study will test blood samples for antibodies and other immunity markers.
How understandable was the trial content above?
Hard to understand
Easy to understand
